Adrian G. Palacios
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adrian G. Palacios has a total of 276 co-authors. Here are the top co-authors by number of shared publications:
- Alvaro Oscar Ardiles
Instituto de Neurociencias, Centro Interdisciplinario de Neurociencias de Valparaíso, Universidad de Valparaíso, Valparaíso, Chile
14 shared publications Francisco Bozinovic
Centro UC Síndrome de Down, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
7 shared publications- María-José Escobar
Universidad Tecnica Federico Santa Maria
7 shared publications - Monica Liliana Acosta
University of Auckland
7 shared publications Alex Vielma
Facultad de Ciencias, Centro Interdisciplinario de Neurociencia de Valparaíso, Universidad de Valparaíso Valparaíso, Chile
5 shared publications- Claudio Hetz
Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile
5 shared publications
Latest Publications
- Open Access
Optimized AAV to express the unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease features in mouse models
Proteostasis impairment at the level of the endoplasmic reticulum (ER) is a salient feature of Alzheimer’s disease (AD). The unfolded protein response (UPR) is the main pathway to cope with ER stress, where the expression of the transcription factor X-Box binding protein 1 (XBP1) is central to establish repair programs. To artificially enforce the adaptive capacity of the UPR in the AD brain, we recently reported the protective effects of overexpressing active XBP1 in the brain using adeno-associated vectors (AAVs) of AD mice, in addition to aged animals. Here we have generated a next generation vector suitable for clinical testing by (i) expressing codon-optimized human XBP1s without artificial tags, (ii) the use of the synapsin promoter to restrict expression to neurons, and (iii) incorporating a novel variant of AAV2 (AAV-TT) with greater biodistribution (here termed Proteostaser-1). Treatment of 5xFAD mice with Proteostaser-1 improved spatial learning and synaptic plasticity, and reduced the deposition of amyloid plaques in the brain. Proteostaser-1 administration also improved cognition in a model of sporadic AD based on the intracerebral injection of amyloid β oligomers. Our results further support the therapeutic potential of the UPR as a strategy to ameliorate AD features and sustain synaptic function.
Open AccessOptimized AAV to express the unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease features in mouse models
Proteostasis impairment at the level of the endoplasmic reticulum (ER) is a salient feature of Alzheimer’s disease (AD). The unfolded protein response (UPR) is the main pathway to cope with ER stress, where the expression of the transcription factor X-Box binding protein 1 (XBP1) is central to establish repair programs. To artificially enforce the adaptive capacity of the UPR in the AD brain, we recently reported the protective effects of overexpressing active XBP1 in the brain using adeno-associated vectors (AAVs) of AD mice, in addition to aged animals. Here we have generated a next generation vector suitable for clinical testing by (i) expressing codon-optimized human XBP1s without artificial tags, (ii) the use of the synapsin promoter to restrict expression to neurons, and (iii) incorporating a novel variant of AAV2 (AAV-TT) with greater biodistribution (here termed Proteostaser-1). Treatment of 5xFAD mice with Proteostaser-1 improved spatial learning and synaptic plasticity, and reduced the deposition of amyloid plaques in the brain. Proteostaser-1 administration also improved cognition in a model of sporadic AD based on the intracerebral injection of amyloid β oligomers. Our results further support the therapeutic potential of the UPR as a strategy to ameliorate AD features and sustain synaptic function.
- Open Access
- 28 February 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (11) , 5230-5231
Blood–retinal biomarker integration for precision prevention of Alzheimer’s disease: Lessons from retinal aging and the unfolded protein response
An abstract is unavailable. This article is available as a PDF only.
- 28 February 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (11) , 5230-5231
Open AccessBlood–retinal biomarker integration for precision prevention of Alzheimer’s disease: Lessons from retinal aging and the unfolded protein response
An abstract is unavailable. This article is available as a PDF only.
- Open Access
Cognitive Resilience in Aging Degus is Linked to CA3 Hippocampal GABAergic Integrity
The preservation of cognitive function during aging remains a key challenge in neuroscience. In this study, we applied an integrative approach, combining behavioral assays with neurophysiological recordings, to investigate hippocampal circuit integrity. We used Octodon degus , a rodent with exceptional longevity (up to 10 years in laboratory conditions), as a natural model of aging and neurodegenerative disease such as Alzheimer. To assess agerelated cognitive changes, we employed three behavioral tasks: Novel Object Recognition (NOR), Open Field (OF), and the Burrowing Test (BT). The BT reflects Activities of Daily Living (ADLs) and is based on species-typical spontaneous burrowing behavior, which has been linked to neurodegenerative markers in degus. We also performed multielectrode electro-physiological recordings to assess GABAergic function in the hippocampus. Aged degus with high BT performance (classified as good burrowers, or GB) showed robust hippocampal activity, especially in the CA3 region, a key hub for signal integration and memory encoding. In contrast, degus with poor BT performance (bad burrowers, or BB) exhibited reduced spontaneous hippocampal activity, suggesting potential compensation via GABA-independent synaptic mechanisms. Altogether, our findings suggest that preserved GABAergic function supports cognitive resilience in aging degus. These results offer new insights into the neural mechanisms underlying healthy cognitive aging and may inform future strategies for preventing or mitigating neurodegeneration.
Open AccessCognitive Resilience in Aging Degus is Linked to CA3 Hippocampal GABAergic Integrity
The preservation of cognitive function during aging remains a key challenge in neuroscience. In this study, we applied an integrative approach, combining behavioral assays with neurophysiological recordings, to investigate hippocampal circuit integrity. We used Octodon degus , a rodent with exceptional longevity (up to 10 years in laboratory conditions), as a natural model of aging and neurodegenerative disease such as Alzheimer. To assess agerelated cognitive changes, we employed three behavioral tasks: Novel Object Recognition (NOR), Open Field (OF), and the Burrowing Test (BT). The BT reflects Activities of Daily Living (ADLs) and is based on species-typical spontaneous burrowing behavior, which has been linked to neurodegenerative markers in degus. We also performed multielectrode electro-physiological recordings to assess GABAergic function in the hippocampus. Aged degus with high BT performance (classified as good burrowers, or GB) showed robust hippocampal activity, especially in the CA3 region, a key hub for signal integration and memory encoding. In contrast, degus with poor BT performance (bad burrowers, or BB) exhibited reduced spontaneous hippocampal activity, suggesting potential compensation via GABA-independent synaptic mechanisms. Altogether, our findings suggest that preserved GABAergic function supports cognitive resilience in aging degus. These results offer new insights into the neural mechanisms underlying healthy cognitive aging and may inform future strategies for preventing or mitigating neurodegeneration.
- Open Access
- 4 August 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (8) , e70497
Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration
Diabetic retinopathy (DR) and Alzheimer's disease (AD) are progressive neurodegenerative disorders affecting the eye and the brain, respectively. Despite targeting different organs, they share common molecular mechanisms. A central process connecting these conditions is the unfolded protein response (UPR), which maintains protein homeostasis in the endoplasmic reticulum (ER). Dysregulation of UPR pathways, particularly the IRE1‐XBP1 and PERK‐eIF2α pathways, can lead to inflammation, oxidative stress, and neurodegeneration. While the IRE1‐XBP1 pathway regulates protein folding and inflammatory signaling, the PERK‐eIF2α pathway reduces protein synthesis but may trigger apoptosis if persistently activated. Emerging therapies targeting UPR pathways and ER chaperones show promise in mitigating neurodegenerative damage in DR and AD. This review highlights shared pathophysiological mechanisms, explore retinal biomarkers for early AD detection, and emphasizes UPR modulation as a therapeutic strategy for neurodegeneration in aging‐related diseases.Highlights: Diabetic retinopathy (DR, ocular disorder) and Alzheimer's disease (AD, cerebral disorder) share common molecular mechanisms, including oxidative stress, inflammation, and proteostasis dysfunction. UPR is a critical pathway linking both diseases through endoplasmic reticulum (ER) stress and neurodegeneration and targeting unfolded protein response (UPR) pathways, ER chaperones (e.g., P58IPK), and anti‐inflammatory treatments show promise. The IRE1‐XBP1 pathway regulates protein homeostasis and inflammation; XBP1s protects against ER stress in both retinal and brain neurons. The PERK‐eIF2α pathway suppresses protein synthesis under stress but may induce apoptosis via ATF4 and CHOP if chronically activated. Age‐related decline in metabolism, proteostasis, and neurovascular function intensifies disease progression and exacerbates molecular and cellular damage in both DR and AD.
- 4 August 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (8) , e70497
Open AccessDiabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration
Diabetic retinopathy (DR) and Alzheimer's disease (AD) are progressive neurodegenerative disorders affecting the eye and the brain, respectively. Despite targeting different organs, they share common molecular mechanisms. A central process connecting these conditions is the unfolded protein response (UPR), which maintains protein homeostasis in the endoplasmic reticulum (ER). Dysregulation of UPR pathways, particularly the IRE1‐XBP1 and PERK‐eIF2α pathways, can lead to inflammation, oxidative stress, and neurodegeneration. While the IRE1‐XBP1 pathway regulates protein folding and inflammatory signaling, the PERK‐eIF2α pathway reduces protein synthesis but may trigger apoptosis if persistently activated. Emerging therapies targeting UPR pathways and ER chaperones show promise in mitigating neurodegenerative damage in DR and AD. This review highlights shared pathophysiological mechanisms, explore retinal biomarkers for early AD detection, and emphasizes UPR modulation as a therapeutic strategy for neurodegeneration in aging‐related diseases.Highlights: Diabetic retinopathy (DR, ocular disorder) and Alzheimer's disease (AD, cerebral disorder) share common molecular mechanisms, including oxidative stress, inflammation, and proteostasis dysfunction. UPR is a critical pathway linking both diseases through endoplasmic reticulum (ER) stress and neurodegeneration and targeting unfolded protein response (UPR) pathways, ER chaperones (e.g., P58IPK), and anti‐inflammatory treatments show promise. The IRE1‐XBP1 pathway regulates protein homeostasis and inflammation; XBP1s protects against ER stress in both retinal and brain neurons. The PERK‐eIF2α pathway suppresses protein synthesis under stress but may induce apoptosis via ATF4 and CHOP if chronically activated. Age‐related decline in metabolism, proteostasis, and neurovascular function intensifies disease progression and exacerbates molecular and cellular damage in both DR and AD.
- Open Access
XBP1s as a Therapeutic Target to Preserve Retinal Function During Aging and Neurodegeneration
Loss of physiological complexity, characterized by reduced adaptive multiscale coordination among system components, is increasingly recognized as a hallmark of aging and neurodegenerative disease. The retina, a window into the brain, offers a unique, accessible platform to monitor neurodegenerative disorders such as Alzheimer’s disease (AD). Here, we investigate the therapeutic potential of the unfolded protein response transcription factor XBP1s in preserving retinal function during aging and AD-related pathology in murine models. Using micro-electroretinography with multielectrode arrays, we recorded retinal responses to chirp and white noise stimuli in four mouse models: wild-type (WT), XBP1s-overexpressing (Tg XBP1s ), AD model (5xFAD), and their crossbreed (Tg XBP1s /5xFAD) at approximately 3 and 7 months of age. We assessed retinal signals through entropy-based complexity measures and wavelet coherence between stimulus and response. While WT and 5xFAD mice exhibited age-related decline in retinal complexity, Tg XBP1s and Tg XBP1s /5xFAD mice maintained higher complexity levels and increased Wcoh in adulthood, indicating functional preservation. These results demonstrate that sus-tained XBP1s expression protects retinal electrophysiological integrity and highlight the retina’s value as a scalable, noninvasive biomarker platform to evaluate therapeutic efficacy targeting neurodegenerative mechanisms.
Open AccessXBP1s as a Therapeutic Target to Preserve Retinal Function During Aging and Neurodegeneration
Loss of physiological complexity, characterized by reduced adaptive multiscale coordination among system components, is increasingly recognized as a hallmark of aging and neurodegenerative disease. The retina, a window into the brain, offers a unique, accessible platform to monitor neurodegenerative disorders such as Alzheimer’s disease (AD). Here, we investigate the therapeutic potential of the unfolded protein response transcription factor XBP1s in preserving retinal function during aging and AD-related pathology in murine models. Using micro-electroretinography with multielectrode arrays, we recorded retinal responses to chirp and white noise stimuli in four mouse models: wild-type (WT), XBP1s-overexpressing (Tg XBP1s ), AD model (5xFAD), and their crossbreed (Tg XBP1s /5xFAD) at approximately 3 and 7 months of age. We assessed retinal signals through entropy-based complexity measures and wavelet coherence between stimulus and response. While WT and 5xFAD mice exhibited age-related decline in retinal complexity, Tg XBP1s and Tg XBP1s /5xFAD mice maintained higher complexity levels and increased Wcoh in adulthood, indicating functional preservation. These results demonstrate that sus-tained XBP1s expression protects retinal electrophysiological integrity and highlight the retina’s value as a scalable, noninvasive biomarker platform to evaluate therapeutic efficacy targeting neurodegenerative mechanisms.
- 27 November 2024
- Published by Springer Nature
- p. 69-91
A General and Accurate Method for Neuronal Ensemble Detection in Spiking Neural Networks
- 27 November 2024
- Published by Springer Nature
- p. 69-91
A General and Accurate Method for Neuronal Ensemble Detection in Spiking Neural Networks
- 31 October 2022
- Published by Springer Nature in The EMBO Journal
- Vol. 41 (22) , e111952
Unfolded protein response IRE1/XBP1 signaling is required for healthy mammalian brain aging
Aging is a major risk factor to develop neurodegenerative diseases and is associated with decreased buffering capacity of the proteostasis network. We investigated the significance of the unfolded protein response (UPR), a major signaling pathway activated to cope with endoplasmic reticulum (ER) stress, in the functional deterioration of the mammalian brain during aging. We report that genetic disruption of the ER stress sensor IRE1 accelerated age-related cognitive decline. In mouse models, overexpressing an active form of the UPR transcription factor XBP1 restored synaptic and cognitive function, in addition to reducing cell senescence. Proteomic profiling of hippocampal tissue showed that XBP1 expression significantly restore changes associated with aging, including factors involved in synaptic function and pathways linked to neurodegenerative diseases. The genes modified by XBP1 in the aged hippocampus where also altered. Collectively, our results demonstrate that strategies to manipulate the UPR in mammals may help sustain healthy brain aging.
- 31 October 2022
- Published by Springer Nature in The EMBO Journal
- Vol. 41 (22) , e111952
Unfolded protein response IRE1/XBP1 signaling is required for healthy mammalian brain aging
Aging is a major risk factor to develop neurodegenerative diseases and is associated with decreased buffering capacity of the proteostasis network. We investigated the significance of the unfolded protein response (UPR), a major signaling pathway activated to cope with endoplasmic reticulum (ER) stress, in the functional deterioration of the mammalian brain during aging. We report that genetic disruption of the ER stress sensor IRE1 accelerated age-related cognitive decline. In mouse models, overexpressing an active form of the UPR transcription factor XBP1 restored synaptic and cognitive function, in addition to reducing cell senescence. Proteomic profiling of hippocampal tissue showed that XBP1 expression significantly restore changes associated with aging, including factors involved in synaptic function and pathways linked to neurodegenerative diseases. The genes modified by XBP1 in the aged hippocampus where also altered. Collectively, our results demonstrate that strategies to manipulate the UPR in mammals may help sustain healthy brain aging.
- Open Access
- 13 April 2021
- Published by Frontiers Media SA in Frontiers in Integrative Neuroscience
- Vol. 15
Ocular Health of Octodon degus as a Clinical Marker for Age-Related and Age-Independent Neurodegeneration
The aging process and age-related diseases such as Alzheimer’s disease (AD), are very heterogeneous and multifactorial, making it challenging to diagnose the disease based solely on genetic, behavioral tests, or clinical history. It is yet to be explained what ophthalmological tests relate specifically to aging and AD. To this end, we have selected the common degu (Octodon degus) as a model for aging which develops AD-like signs to conduct ophthalmological screening methods that could be clinical markers of aging and AD. We investigated ocular health using ophthalmoscopy, fundus photography, intraocular pressure (IOP), and pupillary light reflex (PLR). The results showed significant presence of cataracts in adult degus and IOP was also found to increase significantly with advancing age. Age had a significant effect on the maximum pupil constriction but other pupil parameters changed in an age-independent manner (PIPR retention index, resting pupil size, constriction velocity, redilation plateau). We concluded that degus have underlying factors at play that regulate PLR and may be connected to sympathetic, parasympathetic, and melanopsin retinal ganglion cell (ipRGC) deterioration. This study provides the basis for the use of ocular tests as screening methods for the aging process and monitoring of neurodegeneration in non-invasive ways.
- 13 April 2021
- Published by Frontiers Media SA in Frontiers in Integrative Neuroscience
- Vol. 15
Open AccessOcular Health of Octodon degus as a Clinical Marker for Age-Related and Age-Independent Neurodegeneration
The aging process and age-related diseases such as Alzheimer’s disease (AD), are very heterogeneous and multifactorial, making it challenging to diagnose the disease based solely on genetic, behavioral tests, or clinical history. It is yet to be explained what ophthalmological tests relate specifically to aging and AD. To this end, we have selected the common degu (Octodon degus) as a model for aging which develops AD-like signs to conduct ophthalmological screening methods that could be clinical markers of aging and AD. We investigated ocular health using ophthalmoscopy, fundus photography, intraocular pressure (IOP), and pupillary light reflex (PLR). The results showed significant presence of cataracts in adult degus and IOP was also found to increase significantly with advancing age. Age had a significant effect on the maximum pupil constriction but other pupil parameters changed in an age-independent manner (PIPR retention index, resting pupil size, constriction velocity, redilation plateau). We concluded that degus have underlying factors at play that regulate PLR and may be connected to sympathetic, parasympathetic, and melanopsin retinal ganglion cell (ipRGC) deterioration. This study provides the basis for the use of ocular tests as screening methods for the aging process and monitoring of neurodegeneration in non-invasive ways.
- Open Access
Parallel processing of natural images by overlapping retinal neuronal ensembles
Even though the retinal microcircuit organization has been described in detail at the single-cell level, little is known about how groups of retinal cells’ coordinated activity encode and process parallel information representing the spatial and temporal structure of changing environmental conditions. To describe the population dynamics of retinal neuronal ensembles, we used microelectrode array recordings that describe hundreds of retinal ganglion cells’ simultaneous activity in response to a short movie captured in the natural environment where our subject develops their visual behaviors. The vectorization of population activity allowed the identification of retinal neuronal ensembles that synchronize to specific segments of natural stimuli. These synchronous retinal neuronal ensembles were reliably activated by the same stimuli at different trials, indicating a robust population response of retinal microcircuits. The generation of asynchronous events required integrating a physiologically meaningful time window larger than 80 ms, demonstrating that retinal neuronal ensembles’ time integration filters non-structured visual information. Interestingly, individual neurons could be part of several ensembles indicating that parallel circuits could encode environmental conditions changes. We conclude that parallel neuronal ensembles could represent the functional unit of retinal computations and propose that the further study of retinal neuronal ensembles could reveal emergent properties of retinal circuits that individual cells’ activity cannot explain.
Open AccessParallel processing of natural images by overlapping retinal neuronal ensembles
Even though the retinal microcircuit organization has been described in detail at the single-cell level, little is known about how groups of retinal cells’ coordinated activity encode and process parallel information representing the spatial and temporal structure of changing environmental conditions. To describe the population dynamics of retinal neuronal ensembles, we used microelectrode array recordings that describe hundreds of retinal ganglion cells’ simultaneous activity in response to a short movie captured in the natural environment where our subject develops their visual behaviors. The vectorization of population activity allowed the identification of retinal neuronal ensembles that synchronize to specific segments of natural stimuli. These synchronous retinal neuronal ensembles were reliably activated by the same stimuli at different trials, indicating a robust population response of retinal microcircuits. The generation of asynchronous events required integrating a physiologically meaningful time window larger than 80 ms, demonstrating that retinal neuronal ensembles’ time integration filters non-structured visual information. Interestingly, individual neurons could be part of several ensembles indicating that parallel circuits could encode environmental conditions changes. We conclude that parallel neuronal ensembles could represent the functional unit of retinal computations and propose that the further study of retinal neuronal ensembles could reveal emergent properties of retinal circuits that individual cells’ activity cannot explain.
- Open Access
Control of mammalian brain aging by the unfolded protein response (UPR)
Aging is the major risk factor for the development of dementia and neurodegenerative disorders, and the aging brain manifests severe deficits in buffering capacity by the proteostasis network. Accordingly, we investigated the significance of the unfolded protein response (UPR), a major signaling pathway that copes with endoplasmic reticulum (ER) stress, to normal mammalian brain aging. Genetic disruption of ER stress sensor IRE1α accelerated cognitive and motor dysfunction during aging. Exogenous bolstering of the UPR by overexpressing an active form of the transcription factor XBP1 restored synaptic and cognitive function in addition to reducing cell senescence. Remarkably, proteomic profiling of hippocampal tissue indicated that XBP1s expression corrected age-related alterations in synaptic function. Collectively, our data demonstrate that strategies to manipulate the UPR sustain healthy brain aging. One Sentence Summary: The IRE1/XBP1 pathway dictates when and how brain function declines during aging.
Open AccessControl of mammalian brain aging by the unfolded protein response (UPR)
Aging is the major risk factor for the development of dementia and neurodegenerative disorders, and the aging brain manifests severe deficits in buffering capacity by the proteostasis network. Accordingly, we investigated the significance of the unfolded protein response (UPR), a major signaling pathway that copes with endoplasmic reticulum (ER) stress, to normal mammalian brain aging. Genetic disruption of ER stress sensor IRE1α accelerated cognitive and motor dysfunction during aging. Exogenous bolstering of the UPR by overexpressing an active form of the transcription factor XBP1 restored synaptic and cognitive function in addition to reducing cell senescence. Remarkably, proteomic profiling of hippocampal tissue indicated that XBP1s expression corrected age-related alterations in synaptic function. Collectively, our data demonstrate that strategies to manipulate the UPR sustain healthy brain aging. One Sentence Summary: The IRE1/XBP1 pathway dictates when and how brain function declines during aging.